Icon plans to open a Translational Medicine Research Centre in Manchester

Pharmatimes has reported that Icon has announced plans to further expand its UK hospital-based presence on the Manchester Royal Infirmary Campus by opening a Translational Medicine Research Centre.

ICON has secured a 40,000 square foot pre-let at Citylabs, a newly developed biomedical centre of excellence which was formerly the Manchester Royal Eye Hospital. This new centre will also host biohealth organisations including the Central Manchester University Hospitals NHS Foundation Trust, The University of Manchester, and other commercial research enterprises.

ICON currently operates a hospital-based Clinical Pharmacology Unit on the Manchester Royal Infirmary Campus, where it will continue to run it’s Phase I operations until fully transitioning to the new, larger Citylabs facility, which is scheduled to open in the fourth quarter of 2013.

“We are pleased to be expanding our early phase development services through the establishment of a Centre of Excellence for Translational Medicine in Citylabs,” commented Dr. Mario Rocci, President, ICON Development Solutions. “This expansion will enable ICON to increase the capacity of its Clinical Pharmacology Unit in Manchester as well as the scientific services that are essential in providing a world class offering.”


Are you looking for a new job in the clinical industry?

 Click here to see our latest clinical jobs


Posted in: Industry News, News
CK Logo in place of featured image